All Articles

Beyond one-size-fits-all, GCL SI unveils specialized solar panels for deserts and oceans, backed by a blockchain-verified green supply chain. A new era begins.

As Southeast Asia races to become an EV powerhouse, the real challenge lies on the factory floor. A new wave of traceable assembly tech aims to solve it.

HashKey Holdings plans a HKD100M share buyback, signaling deep confidence in its Web3 strategy despite a slumping stock price. What does this mean for investors?

A breakthrough publication identifies a novel protein, LanCL1, as a key target for neuropathic pain, validating a new class of drugs for millions of sufferers.

A small eco-resort just topped Tripadvisor's global charts. We dissect how Hamanasi’s regenerative model is not just good for the planet, but a masterclass in market dominance.

Sanofi's latest FDA nod for Tzield isn't just a new drug approval; it's a strategic shift from symptom management to disease modification in Type 1 Diabetes.

A landmark 5GWh agreement between Fox ESS and OSW isn't just about storage; it’s a blueprint for a decentralized, resilient, and renewable-powered grid.

A landmark 5GWh battery deal between Fox ESS and Solar Juice signals a major acceleration in Australia's energy transition. Here's how the partnership works.

While Nevada's cannabis market contracts, C21 Investments posts record customer growth and an 8% revenue jump, fueled by a high-stakes tax challenge.

As AI initiatives strain IT budgets, one firm is challenging rigid security contracts with a flexible 'bucket of hours' model for expert identity management.

With its multi-million-dollar makeover, Edge NYC is no longer just an observation deck. Joyce Watson analyzes if its new immersive art can win the skyline wars.

A small business's tip-off led to a federal crackdown on procurement fraud, revealing deep vulnerabilities and renewing the push for a secure American supply chain.

An upcoming London auction reveals a deeper strategy: turning ancient artifacts into a modern asset class by mastering the mechanics of provenance and access.

A massive data breach at benefits firm Paylogix exposes vast sensitive data, placing individuals at risk and revealing deep vulnerabilities in the HR tech industry.

Atossa Therapeutics secures a crucial capital lifeline. We dissect the deal, its impact on a promising cancer drug, and what it reveals about biotech funding today.

Amid widening losses and a squeezed consumer, the children's retailer is monetizing assets and cutting deep into its supply chain. A new team bets on it being enough.

Carol Craig, a trailblazing space entrepreneur, just joined the board of an oil company drilling in the Arctic. Is this tech-fueled innovation or a final, desperate fossil fuel gambit?

PM Carney's new food security plan promises affordability and resilience. But can billions in spending truly break the grocery oligopoly and fix our broken chains?

With a high-yield dividend and perfect rent collection, NewLake Capital signals stability. But is this cannabis REIT a safe haven or just a high-risk reward?

A major data breach at Ohio Living exposes sensitive patient and employee data, echoing a past failure and signaling a deepening crisis for the entire sector.